Classification ![]() |
|
| Compound class | Peptide or derivative |
| Approved drug? | Yes (source: FDA (2017)) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 9794 | abaloparatide |
Synonyms ![]() |
| BA058 |
| Tymlos® |
Database Links ![]() |
|
| Search PubMed clinical trials | abaloparatide |
| Search PubMed titles | abaloparatide |
| Search PubMed titles/abstracts | abaloparatide |
| Wikipedia | BA058 |
| Comments |
| Abaloparatide is a synthetic analogue of the 34 amino-terminal residues of human parathyroid hormone-related protein (PTHrP) [1]. Compare this to the approved drug teriparatide which is a synthetic analogue of human parathyroid hormone (PTH). Abaloparatide and teriparatide are synthetic peptides that help grow and strengthen bone. |